Key Insights
The Vietnamese diabetes care devices market, valued at $424.10 million in 2025, is projected to experience steady growth, driven by rising diabetes prevalence, increasing awareness of self-management techniques, and expanding healthcare infrastructure. The compound annual growth rate (CAGR) of 2.10% from 2025 to 2033 indicates a gradual but consistent market expansion. Key growth drivers include the increasing adoption of advanced technologies like continuous glucose monitoring (CGM) systems, the rising preference for convenient and user-friendly devices like insulin pens and disposable syringes, and government initiatives promoting diabetes management and prevention. However, market growth may be tempered by factors such as high device costs, particularly for advanced technologies like insulin pumps, and limited access to healthcare in certain regions. The market is segmented into monitoring devices (self-monitoring blood glucose devices and CGM systems), lancets, and management devices (insulin pumps, infusion sets, insulin syringes, insulin cartridges, and disposable pens). Major players like Roche, Abbott, Medtronic, and Novo Nordisk are vying for market share, offering a diverse range of products tailored to different patient needs and preferences. Future growth will likely depend on ongoing technological innovations, increased affordability of devices, and targeted public health campaigns focused on diabetes prevention and control.
The competitive landscape features both multinational corporations and local players. The presence of established international players suggests a mature market with robust distribution channels and a focus on product innovation. However, opportunities exist for companies offering affordable and accessible devices tailored to the specific needs and preferences of the Vietnamese population. Furthermore, successful market penetration will depend on effective strategies to increase awareness and education about diabetes management and the benefits of available technologies among both healthcare professionals and patients. A concerted effort to overcome cost barriers and improve access to healthcare across different regions is crucial for realizing the full potential of this market.
Diabetes Care Devices Industry in Vietnam: A Comprehensive Market Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Diabetes Care Devices industry in Vietnam, covering the period from 2019 to 2033. It offers invaluable insights into market dynamics, growth drivers, key players, and future opportunities, making it an essential resource for industry stakeholders, investors, and strategic decision-makers. The report utilizes a robust methodology, incorporating historical data (2019-2024), base year estimates (2025), and forecast data (2025-2033) to provide a holistic view of the market's trajectory. Expect detailed analysis of key segments including Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM), Insulin Pumps, Insulin Syringes, Insulin Cartridges, and Disposable Pens. Leading companies like Roche, Dexcom, Abbott, Medtronic, Novo Nordisk, and many more are analyzed for their market share and strategic maneuvers.
Diabetes Care Devices Industry in Vietnam Market Concentration & Dynamics
The Vietnamese diabetes care devices market exhibits a moderately concentrated landscape, with a few multinational corporations holding significant market share. However, the emergence of local players and the increasing availability of generic products are gradually changing the competitive dynamics. Market concentration is estimated at xx% in 2025, with the top 7 companies holding approximately 72% of the market share. Innovation in the sector is driven by technological advancements in CGM and insulin delivery systems, alongside a growing focus on personalized diabetes management. The regulatory framework, while evolving, is largely aligned with international standards, ensuring patient safety and product efficacy. Substitute products, while limited, include traditional blood glucose monitoring methods, but the shift towards CGM is accelerating. End-user trends showcase a growing preference for convenient, user-friendly, and technologically advanced devices. M&A activities have been relatively modest in recent years, with xx deals recorded during the period 2019-2024, indicating a preference for organic growth over acquisitions.
- Market Concentration (2025): xx%
- Top 7 Companies Market Share (2025): 72%
- M&A Deals (2019-2024): xx
Diabetes Care Devices Industry in Vietnam Industry Insights & Trends
The Vietnamese diabetes care devices market is experiencing robust growth, fueled by rising prevalence of diabetes, increasing healthcare expenditure, and improving access to healthcare services. The market size was estimated at $XX Million in 2025 and is projected to reach $XX Million by 2033, exhibiting a CAGR of xx% during the forecast period. This growth is driven by several factors: an aging population, increasing urbanization, lifestyle changes leading to higher rates of type 2 diabetes, and growing awareness of diabetes management. Technological disruptions, such as the introduction of advanced CGM systems and smart insulin pumps, are revolutionizing diabetes care, enhancing patient outcomes, and increasing market demand. Consumer behavior is shifting towards self-monitoring and personalized care, driving the adoption of technologically advanced devices. Government initiatives aimed at improving diabetes management further contribute to market growth.
Key Markets & Segments Leading Diabetes Care Devices Industry in Vietnam
The market for diabetes care devices in Vietnam shows significant growth across all segments, but certain areas exhibit stronger dominance.
Monitoring Devices: Self-monitoring blood glucose devices (SMBG) currently hold the largest market share due to widespread adoption and relatively lower cost. However, the CGM segment is experiencing rapid growth, fueled by its superior accuracy and convenience.
Management Devices: Insulin pumps are gaining traction, particularly among patients requiring intensive insulin management. The insulin cartridge segment is experiencing relatively slower growth due to the higher initial cost compared to disposable pens. The insulin syringes segment remains a significant part of the market.
Drivers for Growth:
- Rising prevalence of diabetes
- Growing awareness about diabetes management
- Increasing healthcare expenditure
- Government initiatives supporting diabetes care
Dominance Analysis: While SMBG devices dominate in terms of current market share, the CGM segment is poised for significant future growth driven by technological advancements and increased affordability.
Diabetes Care Devices Industry in Vietnam Product Developments
Recent years have witnessed significant product innovations in the Vietnamese diabetes care devices market. The introduction of advanced CGM systems with improved accuracy, longer wear times, and integrated mobile applications has significantly enhanced diabetes management. The development of smart insulin pumps with advanced features like bolus calculators and remote monitoring capabilities has also contributed to improved patient outcomes. These innovations are enabling more personalized and effective diabetes care, leading to enhanced patient compliance and better disease management. Competition is driving continuous innovation in terms of accuracy, ease-of-use, and connectivity.
Challenges in the Diabetes Care Devices Industry in Vietnam Market
The Vietnamese diabetes care devices market faces several challenges. Regulatory hurdles, although easing, can still impact market entry and product approvals. Supply chain complexities can lead to shortages and price fluctuations. The market is characterized by intense competition among multinational corporations and emerging local players, putting pressure on pricing and profitability. The cost of advanced devices like CGM systems remains a significant barrier to wider adoption. The uneven distribution of healthcare resources across the country limits access to these devices in certain regions. These factors collectively contribute to market complexities.
Forces Driving Diabetes Care Devices Industry in Vietnam Growth
Several factors propel the growth of the Vietnamese diabetes care devices market. Technological advancements, particularly in CGM and insulin delivery systems, are improving patient care and driving adoption. Economic growth is boosting healthcare expenditure, making advanced devices more accessible. Government initiatives, focused on improving diabetes management and expanding healthcare access, are supporting market expansion. The rising prevalence of diabetes, along with increased awareness and improved healthcare infrastructure, further accelerate this growth.
Challenges in the Diabetes Care Devices Industry in Vietnam Market
Long-term growth in the Vietnamese diabetes care devices market will hinge on several key factors. Continued innovation in device technology is crucial to maintaining market competitiveness. Strategic partnerships between healthcare providers, device manufacturers, and government agencies can enhance healthcare access and improve patient outcomes. Market expansion into underserved regions is essential to reaching a broader patient population. Focusing on affordability and accessibility of advanced devices is vital for long-term sustainable growth.
Emerging Opportunities in Diabetes Care Devices Industry in Vietnam
The Vietnamese diabetes care devices market presents several exciting opportunities. The expanding middle class and rising healthcare awareness are driving demand for advanced devices. Technological advancements, like AI-powered diabetes management platforms, offer opportunities for innovation. New market segments, such as telehealth and remote patient monitoring, are gaining momentum, providing new avenues for growth. Focus on personalized diabetes management and patient-centric care solutions will be crucial for capturing emerging opportunities.
Leading Players in the Diabetes Care Devices Industry in Vietnam Sector
- Roche
- Dexcom
- Ypsomed
- Abbott
- Eli Lilly
- Sanofi
- Medtronic
- Tandem
- Insulet
- Lifescan (Johnson & Johnson)
- Becton and Dickenson
- Novo Nordisk
Key Milestones in Diabetes Care Devices Industry in Vietnam Industry
- May 2023: Partnership between VPA and Roche Diabetes Care Vietnam to improve healthcare access for children with Type 1 diabetes.
- January 2022: DKK 5 Million grant for research on Gestational Diabetes in Thai Binh province.
- March 2021: Abbott Vietnam introduces the FreeStyle Libre system.
Strategic Outlook for Diabetes Care Devices Industry in Vietnam Market
The Vietnamese diabetes care devices market holds significant growth potential in the coming years. The increasing prevalence of diabetes, coupled with technological advancements and government support, creates a favorable environment for market expansion. Strategic opportunities exist for companies that focus on innovation, affordability, and expanding access to advanced diabetes management technologies. Focusing on patient-centric solutions and building strong partnerships will be key to achieving long-term success in this dynamic market.
Diabetes Care Devices Industry in Vietnam Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Blood Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Insulin Cartridges
- 2.4. Disposable Pens
-
2.1. Insulin Pump
Diabetes Care Devices Industry in Vietnam Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Diabetes Care Devices Industry in Vietnam REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 2.10% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Blood Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Insulin Cartridges
- 5.2.4. Disposable Pens
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Blood Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Insulin Cartridges
- 6.2.4. Disposable Pens
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Blood Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Insulin Cartridges
- 7.2.4. Disposable Pens
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Blood Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Insulin Cartridges
- 8.2.4. Disposable Pens
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Blood Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Insulin Cartridges
- 9.2.4. Disposable Pens
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Blood Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Insulin Cartridges
- 10.2.4. Disposable Pens
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Roche
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom*List Not Exhaustive 7 2 Company Share Analysi
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Ypsomed
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Abbottt
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Medtronic
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Tandem
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Insulet
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Lifescan (Johnson &Johnson)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Becton and Dickenson
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Novo Nordisk
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Roche
List of Figures
- Figure 1: Global Diabetes Care Devices Industry in Vietnam Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Vietnam Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 3: Vietnam Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 9: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 15: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 7: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 8: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 9: United States Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Canada Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Mexico Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 13: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 14: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 15: Brazil Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Argentina Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Rest of South America Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 19: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 20: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 21: United Kingdom Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Germany Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: France Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Italy Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Spain Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Russia Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Benelux Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Nordics Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Rest of Europe Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 31: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 32: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 33: Turkey Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Israel Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: GCC Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: North Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: South Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Rest of Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 40: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 41: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 42: China Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: India Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Japan Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: South Korea Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: ASEAN Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Oceania Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Diabetes Care Devices Industry in Vietnam?
The projected CAGR is approximately 2.10%.
2. Which companies are prominent players in the Diabetes Care Devices Industry in Vietnam?
Key companies in the market include Roche, Dexcom*List Not Exhaustive 7 2 Company Share Analysi, Ypsomed, Abbottt, Eli Lilly, Sanofi, Medtronic, Tandem, Insulet, Lifescan (Johnson &Johnson), Becton and Dickenson, Novo Nordisk.
3. What are the main segments of the Diabetes Care Devices Industry in Vietnam?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 424.10 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
May 2023: The VPA and Roche Diabetes Care Vietnam, represented by Roche Vietnam Company Limited, have partnered to improve healthcare access for disadvantaged children with Type 1 diabetes in Vietnam as part of the global initiative CDiC. Led by Novo Nordisk and Roche Diabetes Care, this program aims to expand healthcare access and provide insulin and supplies to children and young individuals with Type 1 diabetes up to age 25 in countries with limited resources.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Diabetes Care Devices Industry in Vietnam," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Diabetes Care Devices Industry in Vietnam report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Diabetes Care Devices Industry in Vietnam?
To stay informed about further developments, trends, and reports in the Diabetes Care Devices Industry in Vietnam, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
